Location History:
- Kenmore, WA (US) (2022)
- Minneapolis, MN (US) (2022)
Company Filing History:
Years Active: 2022
Title: Ingunn M Stromnes: Innovator in Cancer Immunotherapy
Introduction
Ingunn M Stromnes is a prominent inventor based in Kenmore, WA (US). He has made significant contributions to the field of cancer immunotherapy, focusing on innovative approaches to target Ras neoantigens. His work is pivotal in developing therapies that can potentially treat or prevent cancer.
Latest Patents
Ingunn M Stromnes holds 2 patents. His latest patents include compositions and methods for targeting a Ras antigen, which are crucial for treating or preventing cancer. The disclosed embodiments feature binding proteins, such as T cell receptors or chimeric antigen receptors, that specifically bind to a Ras antigen:HLA complex. Additionally, polynucleotides encoding these binding proteins can be introduced into host cells, such as T cells, for use in immunotherapy. The patents also provide immunogenic polypeptides that can induce an immune response against mutated Ras or help identify binding proteins that target Ras antigens.
Career Highlights
Ingunn M Stromnes is affiliated with the Fred Hutchinson Cancer Center, where he continues to advance research in cancer treatment. His innovative work has positioned him as a key figure in the development of immunotherapeutic strategies.
Collaborations
He collaborates with notable colleagues, including Rachel Perret and Philip D Greenberg, to further enhance the impact of his research in the field of cancer immunotherapy.
Conclusion
Ingunn M Stromnes is a dedicated inventor whose work in targeting Ras neoantigens is paving the way for new cancer treatments. His contributions to immunotherapy are invaluable and hold promise for future advancements in cancer care.